Pamidimukkala, U., Aitcheson, G., Rosenheck, M., Fatima, H., & Obaitan, I. (2024). S2383 The Successful Use of a High-Dose Immunosuppression Combination Regimen for the Management of Refractory IgG4 Sclerosing Cholangitis With Progressive Multisystemic Involvement: A Case Report. The American journal of gastroenterology, 119(10S), S1702. https://doi.org/10.14309/01.ajg.0001038900.94851.5a
Chicago Style (17th ed.) CitationPamidimukkala, Ujwala, Gabriella Aitcheson, Michael Rosenheck, Hala Fatima, and Itegbemie Obaitan. "S2383 The Successful Use of a High-Dose Immunosuppression Combination Regimen for the Management of Refractory IgG4 Sclerosing Cholangitis With Progressive Multisystemic Involvement: A Case Report." The American Journal of Gastroenterology 119, no. 10S (2024): S1702. https://doi.org/10.14309/01.ajg.0001038900.94851.5a.
MLA (9th ed.) CitationPamidimukkala, Ujwala, et al. "S2383 The Successful Use of a High-Dose Immunosuppression Combination Regimen for the Management of Refractory IgG4 Sclerosing Cholangitis With Progressive Multisystemic Involvement: A Case Report." The American Journal of Gastroenterology, vol. 119, no. 10S, 2024, p. S1702, https://doi.org/10.14309/01.ajg.0001038900.94851.5a.